Linked Data API

Show Search Form

Search Results

1127421
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Bacterial Diseases more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 14 May (HL15384), what assessment they have made of the number of people, with or without resistant blood stream infections, who have Carbapenem resistant E. coli-like bacteria present in their bodies; and what (1) proposed, and (2) current, initiatives there are to control the transmission of such bacteria. more like this
tabling member printed
Baroness Gardner of Parkes more like this
uin HL15832 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-04more like thismore than 2019-06-04
answer text <p>The 2018 English surveillance programme for antimicrobial utilisation and resistance report contains information on carbapenem-resistant Escherichia coli (E. coli) causing bloodstream infections in England. In 2017 there were 18 cases. The number of people with other infections and carriage of E. coli resistant to carbapenems is harder to ascertain as surveillance is not as uniform.</p><p>Public Health England (PHE) publishes guidance on the prevention and control of carbapenemase-producing Enterobacteriaceae (including E. coli); guidance is available for both acute and non-acute settings, copies of the <em>Toolkit for managing carbapenemase-producing Enterobacteriaceae in non-acute and community settings</em> and <em>Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae</em> are attached. PHE is supporting actions outlined in the United Kingdom’s Tackling Antimicrobial Resistance National Action Plan that aim to prevent and control the transmission of carbapenem-resistant bacteria, which includes reducing the number of specific drug-resistant infections in people by 10% by 2025; reducing UK antimicrobial use in humans by 15% by 2024; and adding carbapenem-resistant Gram-negative infections to the list of notifiable diseases in existing laboratory reporting systems.</p>
answering member printed Baroness Blackwood of North Oxford more like this
attachment
1
file name Acute_trust_toolkit_for_the_early_detection.pdf remove filter
title Acute trust toolkit more like this
2
file name CPE-Non-AcuteToolkit_CORE.pdf more like this
title CPE Non Acute toolkit more like this
question first answered
less than 2019-06-04T13:45:10.523Zmore like thismore than 2019-06-04T13:45:10.523Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
3596
label Biography information for Baroness Gardner of Parkes more like this